Skip to content
Atogepant and Migraine episode artwork

Oct 13, 2021 21 min

Atogepant and Migraine

from HeadWise

Atogepant (QULIPTA) was just approved by the FDA as a daily oral preventive treatment for migraine. Can we take gepants like Nurtec or Ubrelvy for our acute migraine attacks if we are taking atogepant? How effective is atogepant and what are the side effects? Does it work as well as the injected monoclonal antibodies for migraine prevention? On this episode, Lindsay Weitzel, PhD, asks migraine clinical trial expert Tim Smith, MD, all the hard questions.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Atogepant and Migraine

0:00 21:42

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of HeadWise?

This episode is 21 minutes long.

When was this HeadWise episode published?

This episode was published on October 13, 2021.

Can I download this HeadWise episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.